ClinicalTrials.gov record
Completed Phase 2 Interventional

HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903

ClinicalTrials.gov ID: NCT04975698

Public ClinicalTrials.gov record NCT04975698. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 21, 2026, 12:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Administration of HIV-specific T Cells to HIV+ Patients Receiving High Dose Chemotherapy Followed by Autologous Stem Cell Rescue - Auto -RESIST BMT CTN 1903

Study identification

NCT ID
NCT04975698
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Catherine Bollard
NIH
Enrollment
12 participants

Conditions and interventions

Interventions

  • Bone Marrow Transplant Biological
  • HST-NEETs Biological

Biological

Eligibility (public fields only)

Age range
15 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 24, 2021
Primary completion
Nov 23, 2025
Completion
Jan 4, 2026
Last update posted
Mar 24, 2026

2021 – 2026

United States locations

U.S. sites
11
U.S. states
9
U.S. cities
9
Facility City State ZIP Site status
City of Hope National Medical Center Duarte California 91010
Georgetown Washington D.C. District of Columbia 20057
H. Lee Moffitt Cancer Center Tampa Florida 33612
Northside Atlanta Georgia 30342
University of Illinois Chicago Illinois 60612
Johns Hopkins University Baltimore Maryland 21231
Icahn School of Medicine at Mount Sinai New York New York 10029
Memorial Sloan Kettering (MSKCC) New York New York 10065
University of Pennsylvania Philadelphia Pennsylvania 19104
Baylor College of Medicine Houston Texas 77030
MD Anderson Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04975698, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 24, 2026 · Synced May 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04975698 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →